SAR448851

DRUG2 trials

Sponsors

Sanofi-Aventis Recherche & Developpement, Sanofi

Conditions

Alzheimer's DiseaseDementia Alzheimer's typeDementia, Alzheimer's Type

Phase 2

A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease

RecruitingNCT07688213

SanofiDementia, Alzheimer's Type, Alzheimer's Disease

Start: 2026-07-28End: 2029-07-31Target: 160Updated: 2026-08-10

A Phase 2, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of 48-week SAR448851 treatment followed by open-label extension in participants with early Alzheimer’s disease.

Not yet recruitingCTIS2025-524581-14-00

Sanofi-Aventis Recherche & DeveloppementDementia Alzheimer's type

Target: 213Updated: 2026-08-18